Education
About Us
Working with TipRanks
Follow Us
Australian Clinical Labs Ltd (AU:ACL)
ASX:ACL
RESEARCH TOOLSreports
ACL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$2.14 - AU$3.86
Previous CloseN/A
Volume421.17K
Average Volume (3M)904.91K
Market Cap
AU$581.81M
Enterprise ValueAU$781.76M
Total Cash (Recent Filing)AU$34.85M
Total Debt (Recent Filing)AU$157.76M
Price to Earnings (P/E)19.0
Beta0.89
Next Earnings
Aug 20, 2025EPS Estimate
0.13Last Dividend Ex-Date
Mar 27, 2025Dividend Yield4.27%
Share Statistics
EPS (TTM)0.15
Shares Outstanding198,568,900
10 Day Avg. Volume652,527
30 Day Avg. Volume904,914
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)N/A
Price to Sales (P/S)0.87
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$3.56Price Target Upside20.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
---
Australian Clinical Labs Ltd News
PremiumCompany Announcements
Australian Clinical Labs Updates on Securities Buy-Back
PremiumCompany Announcements
Leadership Transition at Australian Clinical Labs
PremiumCompany Announcements
KKR Entities Increase Stake in Australian Clinical Labs Ltd
PremiumCompany Announcements
Australian Clinical Labs Announces Share Registry Address Change
PremiumCompany Announcements
Australian Clinical Labs Ltd Sees Change in Substantial Holding
PremiumCompany Announcements
Substantial Holder Reduces Stake in Australian Clinical Labs---
Options Prices
Currently, No data available
---
Ownership Overview
<0.01%
Insiders
2.22%
Mutual Funds
― Other Institutional Investors
96.05% Public Companies and
Individual Investors
ACL FAQ
What was Australian Clinical Labs Ltd’s price range in the past 12 months?
Australian Clinical Labs Ltd lowest share price was AU$2.14 and its highest was AU$3.85 in the past 12 months.
What is Australian Clinical Labs Ltd’s market cap?
Australian Clinical Labs Ltd’s market cap is AU$581.81M.
When is Australian Clinical Labs Ltd’s upcoming earnings report date?
Australian Clinical Labs Ltd’s upcoming earnings report date is Aug 20, 2025 which is in 117 days.
How were Australian Clinical Labs Ltd’s earnings last quarter?
Australian Clinical Labs Ltd released its earnings results on Feb 25, 2025. The company reported AU$0.059 earnings per share for the quarter, missing the consensus estimate of AU$0.07 by -AU$0.011.
Is Australian Clinical Labs Ltd overvalued?
According to Wall Street analysts Australian Clinical Labs Ltd’s price is currently Undervalued.
Does Australian Clinical Labs Ltd pay dividends?
Australian Clinical Labs Ltd pays a Annually dividend of AU$0.035 which represents an annual dividend yield of 4.27%. See more information on Australian Clinical Labs Ltd dividends here
What is Australian Clinical Labs Ltd’s EPS estimate?
Australian Clinical Labs Ltd’s EPS estimate is 0.13.
How many shares outstanding does Australian Clinical Labs Ltd have?
Australian Clinical Labs Ltd has 198,568,900 shares outstanding.
What happened to Australian Clinical Labs Ltd’s price movement after its last earnings report?
Australian Clinical Labs Ltd reported an EPS of AU$0.059 in its last earnings report, missing expectations of AU$0.07. Following the earnings report the stock price went down -11.749%.
Which hedge fund is a major shareholder of Australian Clinical Labs Ltd?
Currently, no hedge funds are holding shares in AU:ACL
---
Australian Clinical Labs Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$3.56 (20.68% Upside)
AU$3.56 (20.68% Upside)
Blogger Sentiment
Bullish
AU:ACL Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
25.79%
12-Months-Change
Fundamentals
Return on Equity
18.39%
Trailing 12-Months
Asset Growth
0.23%
Trailing 12-Months
Company Description
Australian Clinical Labs Ltd
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
---
ACL Stock 12 Month Forecast
Average Price Target
AU$3.56
▲(20.68% Upside)
Technical Analysis
Healius Limited
―
Ramsay Health Care
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Best Analysts Covering ACL
1 Year
1 Year Success Rate
3/7 ratings generated profit
1 Year Average Return
-5.64%
reiterated a buy rating 3 months ago
Copying Mathieu Chevrier's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -5.64% per trade.
---